PDF herunterladen
Semin Respir Crit Care Med 2023; 44(02): 269-286
DOI: 10.1055/s-0042-1758732
Review Article

Microbial Epidemiology of the Cystic Fibrosis Airways: Past, Present, and Future

Christina S. Thornton
1   Department of Medicine, Cumming School of Medicine, University of Calgary, Alberta, Canada
,
Michael D. Parkins
1   Department of Medicine, Cumming School of Medicine, University of Calgary, Alberta, Canada
2   Department of Microbiology, Immunology and Infectious Diseases, University of Calgary, Alberta, Canada
› Institutsangaben
› Weitere Informationen
   Lizenzen und Reprints
Zoom Image

Abstract

Progressive obstructive lung disease secondary to chronic airway infection, coupled with impaired host immunity, is the leading cause of morbidity and mortality in cystic fibrosis (CF). Classical pathogens found in the airways of persons with CF (pwCF) include Pseudomonas aeruginosa, Staphylococcus aureus, the Burkholderia cepacia complex, Achromobacter species, and Haemophilus influenzae. While traditional respiratory-tract surveillance culturing has focused on this limited range of pathogens, the use of both comprehensive culture and culture-independent molecular approaches have demonstrated complex highly personalized microbial communities. Loss of bacterial community diversity and richness, counteracted with relative increases in dominant taxa by traditional CF pathogens such as Burkholderia or Pseudomonas, have long been considered the hallmark of disease progression. Acquisition of these classic pathogens is viewed as a harbinger of advanced disease and postulated to be driven in part by recurrent and frequent antibiotic exposure driven by frequent acute pulmonary exacerbations. Recently, CF transmembrane conductance regulator (CFTR) modulators, small molecules designed to potentiate or restore diminished protein levels/function, have been successfully developed and have profoundly influenced disease course. Despite the multitude of clinical benefits, structural lung damage and consequent chronic airway infection persist in pwCF. In this article, we review the microbial epidemiology of pwCF, focus on our evolving understanding of these infections in the era of modulators, and identify future challenges in infection surveillance and clinical management.

Keywords

cystic fibrosis - epidemiology - microbiology - microbiome - CFTR modulators


Publikationsverlauf

Artikel online veröffentlicht:
09. Januar 2023

© 2023. Thieme. All rights reserved.

Thieme Medical Publishers, Inc.
333 Seventh Avenue, 18th Floor, New York, NY 10001, USA